IBM Takes Life Sciences Business to Next Level with New Worldwide Consulting Practice

Consultants will help companies leverage IT for faster drug discovery and development

Select a topic or year

SOMERS, N.Y. - 06 Mar 2001: IBM will expand its reach into the fast-growing life sciences marketplace by establishing a consulting practice within its Global Services organization.

The Global Life Sciences Consulting and Solutions practice announced today will help biotech and pharmaceutical research and development organizations use information technology to accelerate the development of new medical treatments. Existing and future life sciences partners will now be able to benefit from IBM's expertise in consulting, systems integration and strategic outsourcing in the areas of data management, knowledge management and e-business services.

"Information technology is key to modernizing the drug discovery and development process," said Frank Roney, general manager, Business Innovation Services, Worldwide IBM Global Services. "We're drawing on IBM's extensive services capabilities and expertise to help companies transform their R&D units into more efficient and competitive operations."

The life sciences industry's appetite for information technology services continues to grow. A recent Frost & Sullivan study done for IBM predicted that life sciences companies will spend nearly $6.5 billion on IT services by 2004.

"This announcement underscores the reason we formed an alliance with IBM -- its ability to provide an unparalleled breadth and depth of technology and services," said Frank Gleeson, president & CEO of MDS Proteomics. "We have successfully integrated IBM's high performance computing infrastructure across a variety of platforms and industry-specific consulting and integration services with MDS Proteomics' biology expertise, bioinformatics capability and leading-edge proteomics research techniques. The result is rapidly advanced proteomics research which will, ultimately, speed the development of more efficient and effective medicines."

IBM is developing a portfolio of solutions and services to help customers create world-class environments for drug discovery and clinical development. The initial suite of offerings includes:

Knowledge Management: IBM will provide the technology infrastructure and services to help researchers and scientists harvest and share information and knowledge through teams and research communities that foster innovation, improve productivity and enhance collaboration.

Data Management and Integration: IBM's services will help companies manage the vast and growing amounts of genomic, proteomic and other research data supporting drug discovery. Solutions will leverage IBM's DiscoveryLink technology to simplify data gathering and analysis, improve research and development cycles, and lower drug development costs.

Clinical Trial e-Enablement: IBM will offer services to help pharmaceutical, biotechnology and other companies take advantage of the Internet to improve efficiency and shorten the cycle time of clinical trials. With its business partners, IBM will implement solutions for electronic data capture, data management, hosting and systems integration.

Hosting Services: IBM's technology enablement and hosting services allow pharmaceutical and biotechnology customers to focus their resources on core business areas, while helping to lower information technology costs. The comprehensive portfolio of hosting solutions ranges from Web site and application infrastructure management to outsourcing.

The new consulting group's offerings, which will be available worldwide, will be rolled out in phases across the pharmaceutical R&D and biotechnology sectors, and will build on IBM Global Services' momentum in the health care industry. IBM Global Services is the leading outsourcer for the world's largest pharmaceutical companies.

IBM Life Sciences brings together IBM resources -- from research and e-business expertise to data and storage management and high-performance computing -- to deliver new solutions to the life sciences market, including biotechnology, genomic, e-health, pharmaceutical and agri-business companies. For more information on IBM Life Sciences, visit

# # #

Related XML feeds
Topics XML feeds
Financial news, company earnings, philanthropy, community service, human resources, sponsorship
Services and solutions